TY  - GEN
AU  - Lawrence,N
AU  - Martin,A
AU  - Toner,G
AU  - Stockler,M
AU  - Buizen,L
AU  - Thomson,D
AU  - Gebski,V
AU  - Friedlander,M
AU  - Yeung,A
AU  - Wong,N
AU  - Gurney,H
AU  - Rosenthal,M
AU  - Singhal,N
AU  - Kichenadasse,G
AU  - Wong,S
AU  - Lewis,C
AU  - Vasey,P
AU  - Grimison,P
TI  - Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
SN  - 1569-8041
PY  - 2018///0123
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Australia
KW  - epidemiology
KW  - Bleomycin
KW  - Cisplatin
KW  - Clinical Trials, Phase II as Topic
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Male
KW  - Multicenter Studies as Topic
KW  - Neoplasms, Germ Cell and Embryonal
KW  - diagnosis
KW  - New Zealand
KW  - Prostatic Neoplasms
KW  - Time Factors
KW  - Treatment Outcome
KW  - Urogenital Neoplasms
N1  - Publication Type: Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdw313
ER  -